These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15459024)

  • 1. Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes: broadening the clinical picture to include progressive supranuclear palsy.
    Paviour DC; Lees AJ; Josephs KA; Ozawa T; Ganguly M; Strand C; Godbolt A; Howard RS; Revesz T; Holton JL
    Brain; 2004 Nov; 127(Pt 11):2441-51. PubMed ID: 15459024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.
    Josephs KA; Petersen RC; Knopman DS; Boeve BF; Whitwell JL; Duffy JR; Parisi JE; Dickson DW
    Neurology; 2006 Jan; 66(1):41-8. PubMed ID: 16401843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions.
    Mackenzie IR; Foti D; Woulfe J; Hurwitz TA
    Brain; 2008 May; 131(Pt 5):1282-93. PubMed ID: 18362096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FTLD-TDP with motor neuron disease, visuospatial impairment and a progressive supranuclear palsy-like syndrome: broadening the clinical phenotype of TDP-43 proteinopathies. A report of three cases.
    Rusina R; Kovacs GG; Fiala J; Hort J; Ridzoň P; Holmerová I; Ströbel T; Matěj R
    BMC Neurol; 2011 May; 11():50. PubMed ID: 21569259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin immunohistochemistry of frontotemporal lobar degeneration differentiates cases with and without motor neuron disease.
    Katsuse O; Dickson DW
    Alzheimer Dis Assoc Disord; 2005; 19 Suppl 1():S37-43. PubMed ID: 16317257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration.
    Cairns NJ; Bigio EH; Mackenzie IR; Neumann M; Lee VM; Hatanpaa KJ; White CL; Schneider JA; Grinberg LT; Halliday G; Duyckaerts C; Lowe JS; Holm IE; Tolnay M; Okamoto K; Yokoo H; Murayama S; Woulfe J; Munoz DG; Dickson DW; Ince PG; Trojanowski JQ; Mann DM;
    Acta Neuropathol; 2007 Jul; 114(1):5-22. PubMed ID: 17579875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
    Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
    Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are frontotemporal lobar degeneration, progressive supranuclear palsy and corticobasal degeneration distinct diseases?
    Sha S; Hou C; Viskontas IV; Miller BL
    Nat Clin Pract Neurol; 2006 Dec; 2(12):658-65. PubMed ID: 17117169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementias.
    Mott RT; Dickson DW; Trojanowski JQ; Zhukareva V; Lee VM; Forman M; Van Deerlin V; Ervin JF; Wang DS; Schmechel DE; Hulette CM
    J Neuropathol Exp Neurol; 2005 May; 64(5):420-8. PubMed ID: 15892300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation.
    Shi J; Shaw CL; Du Plessis D; Richardson AM; Bailey KL; Julien C; Stopford C; Thompson J; Varma A; Craufurd D; Tian J; Pickering-Brown S; Neary D; Snowden JS; Mann DM
    Acta Neuropathol; 2005 Nov; 110(5):501-12. PubMed ID: 16222525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinically undetected motor neuron disease in pathologically proven frontotemporal lobar degeneration with motor neuron disease.
    Josephs KA; Parisi JE; Knopman DS; Boeve BF; Petersen RC; Dickson DW
    Arch Neurol; 2006 Apr; 63(4):506-12. PubMed ID: 16606762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TDP-43 in ubiquitinated inclusions in the inferior olives in frontotemporal lobar degeneration and in other neurodegenerative diseases: a degenerative process distinct from normal ageing.
    Davidson Y; Amin H; Kelley T; Shi J; Tian J; Kumaran R; Lashley T; Lees AJ; DuPlessis D; Neary D; Snowden J; Akiyama H; Arai T; Hasegawa M; Bandopadhyay R; Sikkink S; Pickering-Brown S; Mann DM
    Acta Neuropathol; 2009 Sep; 118(3):359-69. PubMed ID: 19330339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White matter lesions in the brain with frontotemporal lobar degeneration with motor neuron disease: TDP-43-immunopositive inclusions co-localize with p62, but not ubiquitin.
    Hiji M; Takahashi T; Fukuba H; Yamashita H; Kohriyama T; Matsumoto M
    Acta Neuropathol; 2008 Aug; 116(2):183-91. PubMed ID: 18584184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FTLD-TDP and progressive supranuclear palsy in comorbidity-a report of two cases with different clinical presentations.
    Storey K; Johanidesová S; Matěj R; Keller J; Rohan Z; Rusina R
    Neurocase; 2017 Feb; 23(1):5-11. PubMed ID: 27915581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippocampal sclerosis in tau-negative frontotemporal lobar degeneration.
    Josephs KA; Dickson DW
    Neurobiol Aging; 2007 Nov; 28(11):1718-22. PubMed ID: 16930776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy.
    Sakae N; Josephs KA; Litvan I; Murray ME; Duara R; Uitti RJ; Wszolek ZK; Graff-Radford NR; Dickson DW
    Mov Disord; 2019 Nov; 34(11):1655-1662. PubMed ID: 31433871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI signatures of the frontotemporal lobar degeneration continuum.
    Agosta F; Galantucci S; Magnani G; Marcone A; Martinelli D; Antonietta Volontè M; Riva N; Iannaccone S; Ferraro PM; Caso F; Chiò A; Comi G; Falini A; Filippi M
    Hum Brain Mapp; 2015 Jul; 36(7):2602-14. PubMed ID: 25821176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitin-positive inclusions and progression of pathology in frontotemporal dementia and motor neurone disease identifies a group with mainly early pathology.
    Kersaitis C; Halliday GM; Xuereb JH; Pamphlett R; Bak TH; Hodges JR; Kril JJ
    Neuropathol Appl Neurobiol; 2006 Feb; 32(1):83-91. PubMed ID: 16409556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies.
    Sampathu DM; Neumann M; Kwong LK; Chou TT; Micsenyi M; Truax A; Bruce J; Grossman M; Trojanowski JQ; Lee VM
    Am J Pathol; 2006 Oct; 169(4):1343-52. PubMed ID: 17003490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological characterization of Pick's disease versus frontotemporal lobar degeneration with ubiquitin/TDP-43-positive inclusions.
    Yokota O; Tsuchiya K; Arai T; Yagishita S; Matsubara O; Mochizuki A; Tamaoka A; Kawamura M; Yoshida H; Terada S; Ishizu H; Kuroda S; Akiyama H
    Acta Neuropathol; 2009 Apr; 117(4):429-44. PubMed ID: 19194716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.